USD
GBP 
CNY 
EUR 
INR 
JPY 
MYR 
ZAR 
KRW 
THB 
A New World of Microbiome Innovations
28-Jun-2017
Global
Technology Research
D7B3-01-00-00-00
HC02836-GL-TR_20310
Microbiome science has become a key area of research for biopharmaceutical companies. At present, there are multiple start-ups emerging, which are focusing their resources towards the development of novel therapeutics as well as diagnostic/screening technologies and services. In an era of personalized medicine, the current trajectory of growth witness across the microbiome industry parallels, the growth that took place across genomics. Some of the milestones that have occurred in the microbiome field are the application of next generation screening towards identifying and assessing microbial levels within the human gut. Using these microbial biomarkers, scientists are pushing the boundaries by identifying novel drug targets as well as probiotic or prebiotic products that could aid in balancing the microbial ecosystem within the human body.
1.1 Key Findings
1.2 Interest Across The “Microbiome” Rapidly Rising
1.3 The Past, Present & Future of Human Microbiomics
1.4 Microbiome Product Diversity And Segmentation
2.1 Technology Overview: Therapeutics
2.2 Technology Overview: Over-the-counter
2.3 Technology Overview: Diagnostic Products & Services
3.1 More than 50% of all Microbiome Research is Focused Towards the GI
3.2 Multiple Diseases Have Unmet Therapeutics Needs
3.3 Clostridium difficile Threat Increasing due to Increasing Antibiotic use
3.4 Inflammatory Bowel Disease Another Large Unmet Area of Urgent Need
3.5 Skin Disorders Have Found A New Age Therapeutic Solution
3.6 Lifestyle Disorders Could Also Be Controlled Through the Microbiome
3.7 Immune-Microbiome A New Avenue In Cancer Research
3.8 OTC Microbiome Products Have Numerous Consumer Target Segments
3.9 OTC Microbiome Products Promote A Balanced Micro-ecosystem
3.10 Documented Usage of Probiotics Across Human Health is Diverse
4.1 Largest Contribution Towards the Microbiome Product Landscape Comes from Probiotic Drugs
4.2 Microbiome Therapeutics are Developed to with a Strategic Technical Design Based Approach
4.3 OTC Microbiome Products – Key Segments
4.4 OTC Microbiome Products – Some Probiotics/Prebiotic Stakeholders
4.5 Current Microbiome Company Ecosystem Segmented by Technology Focus
4.6 Microbiome Stakeholders Mergers, Acquisitions & Partnerships Snapshot
5.1 Approach–Company Profile
5.2 Seres Health (Seres Therapeutics)
5.3 AvidBiotics
5.4 Rebiotix
5.5 Ritter Pharmaceutical
5.6 Vedanta Biosciences
5.7 C3 Jian
6.1 Regional Analysis of OTC Health Innovations
6.2 Regional Analysis of Diagnostic/Services Innovations
6.3 Technology Roadmap
7.1 Growth Opportunity 7: Microbiome
7.2 Major Growth Opportunities for Microbiome
7.3 Strategic Imperatives for Microbiome Technology Stakeholders
Legal Disclaimer
8.1 The Frost & Sullivan Story
8.2 Value Proposition: Future of Your Company & Career
8.3 Global Perspective
8.4 Industry Convergence
8.5 360º Research Perspective
8.6 Implementation Excellence
8.7 Our Blue Ocean Strategy
Speak directly with our analytics experts for tailored recommendations.
Recent related Healthcare research
15 Sep 2026 | Global | Market Research
Vendor Profiles: Advanced Wound Care Management Market, Global, 2025
The wound care market is being transformed by advanced technologies and evolving care models that focus on improving patient outcomes and reducing healthcare costs. Innovations such as smart sensor-embedded dressings, artificial intelligence (AI)-based wound imaging systems, enhanced negative pressu...
11 Sep 2026 | Global | Frost Radar
Frost Radar™: Pharmaceutical Commercialization Solutions and Services, 2026
Pharmaceutical commercialization is a multidimensional concept in the successful launch and distribution of a drug. The process includes the development of a pricing strategy that reflects the drug’s value, negotiation with payers to ensure drug cost coverage, regulatory compliance, and the generati...
07 Sep 2026 | Global | Technology Research
Synthetic Antibodies and AI-Optimized Immunotherapies
Artificial intelligence is becoming increasingly relevant to antibody discovery and immunotherapy development, supporting target identification, de novo antibody design, antibody engineering, clinical intelligence, and bioprocessing. Advances in generative AI, protein language models, diffusion mode...
28 Aug 2026 | Global | Technology Research
Innovations and Growth Opportunities in Advanced Medical Devices, Artificial Intelligence Solutions, Digital Solutions, and Medical Imaging Solutions
The latest issue of Advanced MedTech Technology Opportunity Engine (TOE) spotlights a diverse slate of innovations across advanced medical devices, artificial intelligence solutions, digital solutions, and medical imaging solutions.The issue features advanced medical devices such as active bioelectr...
27 Aug 2026 | Global | Frost Radar
Frost Radar: AI-Powered Molecular Diagnostics, 2026
AI-powered molecular diagnostics is an emerging and moderately fragmented industry that includes molecular diagnostics companies, precision medicine platforms, sequencing specialists, AI-driven analytics providers, and disease-focused biotechnology companies. No single company has dominated, present...
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.
| Deliverable Type | Technology Research |
|---|---|
| No Index | No |
| Podcast | No |
| Author | Madhumitha Rangesa |
| Industries | Healthcare |
| WIP Number | D7B3-01-00-00-00 |
| Is Prebook | No |
Microbiome Technologies Energizing Pharma and Life Sciences
$4,950.00
Special Price $3,712.50 save 25 %